110 related articles for article (PubMed ID: 8236191)
1. [New cancer disease after treatment of Hodgkin's disease].
Abrahamsen JF; Andersen A; Hannisdal E; Nome O; Kvaløy SO; Høst H; Abrahamsen AF
Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2903-5. PubMed ID: 8236191
[TBL] [Abstract][Full Text] [Related]
2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
3. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
5. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease.
Henry-Amar M
NCI Monogr; 1988; (6):65-72. PubMed ID: 3352791
[TBL] [Abstract][Full Text] [Related]
6. Risk of second cancers after treatment for Hodgkin's disease.
Tucker MA; Coleman CN; Cox RS; Varghese A; Rosenberg SA
N Engl J Med; 1988 Jan; 318(2):76-81. PubMed ID: 3336397
[TBL] [Abstract][Full Text] [Related]
7. Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82.
Greene MH; Wilson J
Natl Cancer Inst Monogr; 1985 Dec; 68():191-217. PubMed ID: 4088298
[TBL] [Abstract][Full Text] [Related]
8. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
Forrest DL; Hogge DE; Nevill TJ; Nantel SH; Barnett MJ; Shepherd JD; Sutherland HJ; Toze CL; Smith CA; Lavoie JC; Song KW; Voss NJ; Gascoyne RD; Connors JM
J Clin Oncol; 2005 Nov; 23(31):7994-8002. PubMed ID: 16204014
[TBL] [Abstract][Full Text] [Related]
9. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
Tavernier E; Le QH; de Botton S; Dhédin N; Bulabois CE; Reman O; Vey N; Lhéritier V; Dombret H; Thomas X
Cancer; 2007 Dec; 110(12):2747-55. PubMed ID: 17963265
[TBL] [Abstract][Full Text] [Related]
10. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
11. Second malignant tumours in childhood Hodgkin's disease.
Jenkin D; Greenberg M; Fitzgerald A
Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
[TBL] [Abstract][Full Text] [Related]
12. [Descriptive and analytical epidemiology of second primaries in Osaka, Japan].
Tsukuma H; Tanaka H; Koyama Y; Kinoshita N; Koyama H; Furukawa H
Gan To Kagaku Ryoho; 1999 Nov; 26(13):1980-7. PubMed ID: 10584561
[TBL] [Abstract][Full Text] [Related]
13. Second malignancies following treatment for Hodgkin's disease: a Greek experience.
Economopoulos T; Stathakis N; Alexopoulos C; Pavlidis N; Constantinidou M; Briassoulis E; Papageorgiou E; Dervenoulas J; Pappa V; Vaslamatzis M
Haematologica; 1994; 79(3):273-6. PubMed ID: 7926979
[TBL] [Abstract][Full Text] [Related]
14. Solid second cancers following Hodgkin's disease.
Tucker MA
Hematol Oncol Clin North Am; 1993 Apr; 7(2):389-400. PubMed ID: 8468272
[TBL] [Abstract][Full Text] [Related]
15. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.
Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC
J Clin Oncol; 2006 Apr; 24(10):1568-74. PubMed ID: 16520465
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the risk of solid tumor following Hodgkin's disease.
Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
[TBL] [Abstract][Full Text] [Related]
17. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy.
Kawaguchi T; Matsumura A; Iuchi K; Ishikawa S; Maeda H; Fukai S; Komatsu H; Kawahara M
Jpn J Clin Oncol; 2006 Jan; 36(1):7-11. PubMed ID: 16368713
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
19. [Hodgkin's lymphoma and secondary leukemias].
Centurioni R; Brianzoni MF; Salvi A; Montillo M; Rupoli S; Olivieri A; Leoni P; Danieli G
Recenti Prog Med; 1993 May; 84(5):328-35. PubMed ID: 8511392
[TBL] [Abstract][Full Text] [Related]
20. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
Guérin S; Hawkins M; Shamsaldin A; Guibout C; Diallo I; Oberlin O; Brugières L; de Vathaire F
J Clin Oncol; 2007 Jul; 25(19):2833-9. PubMed ID: 17602088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]